Updates are available Correction dated 2018-12-14
Click to view Correction: https://doi.org/10.1038/s41591-018-0315-0
-
Authors
Kisalu, Neville K
Idris, Azza H
Weidle, Connor
Flores-Garcia, Yevel
Flynn, Barbara J
Sack, Brandon K http://orcid.org/0000-0002-5577-7787
Murphy, Sean
Schön, Arne
Freire, Ernesto
Francica, Joseph R
Miller, Alex B
Gregory, Jason
March, Sandra
Liao, Hua-Xin
Haynes, Barton F
Wiehe, Kevin
Trama, Ashley M
Saunders, Kevin O
Gladden, Morgan A
Monroe, Anthony
Bonsignori, Mattia
Kanekiyo, Masaru http://orcid.org/0000-0001-5767-1532
Wheatley, Adam K
McDermott, Adrian B
Farney, S Katie
Chuang, Gwo-Yu
Zhang, Baoshan
Kc, Natasha
Chakravarty, Sumana
Kwong, Peter D
Sinnis, Photini
Bhatia, Sangeeta N
Kappe, Stefan H I
Sim, B Kim Lee http://orcid.org/0000-0002-8598-8905
Hoffman, Stephen L
Zavala, Fidel
Pancera, Marie
Seder, Robert A
- License Information
-
More Information
Article History
Received: 22 January 2018
Accepted: 26 January 2018
First Online: 19 March 2018
Competing interests
: N.K., S.C., B.K.L.S. and S.L.H. are salaried employees of Sanaria Inc., the developer and owner of the PfSPZ Vaccine and the sponsor of the clinical trials. In addition, S.L.H. and B.K.L.S. have a financial interest in Sanaria Inc. All other authors declare no competing financial interests.
